权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Roles for Intracellular pH Dynamics in Cancer

细胞内 pH 动态在癌症中的作用

基本信息

批准号：
9487198
负责人：
DIANE L BARBER
金额：
$ 41.59万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-06-01 至 2021-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9487198
关键词：
6-Phosphofructokinase Address Adult Affinity Amino Acid Substitution Amino Acids BRAF gene Behavior Biochemistry Bioinformatics Biosensor Cancer Cluster Carbon Cell Cycle Progression Cell physiology Cells Cellular Morphology Cellular biology Classification Consumption Data Databases Detection Disease Progression Drosophila genus Dysplasia Enzymes Epidermal Growth Factor Receptor Exploratory/Developmental Grant for Diagnostic Cancer Imaging Genetic Glucose Glycolysis Heterogeneity Histidine International Lactate Dehydrogenase Ligand Binding Magnetic Resonance Spectroscopy Malignant Neoplasms Measures Mediating Metabolic Metabolism Methods Mitochondria Mitochondrial Matrix Molecular Molecular Conformation Mutation Neoplasm Metastasis Normal Cell Oncogenes Oncogenic Outcome Oxidative Phosphorylation PHluorin Post-Translational Protein Processing Property Protein Conformation Proteins Proton-Motive Force Publishing Reporting Role Shapes Signal Pathway Somatic Mutation TP53 gene Testing Therapeutic Time Tissues United States National Institutes of Health Warburg Effect Work aerobic glycolysis base cancer cell cancer subtypes cancer type cell behavior cell motility design in vivo insight lysylglutamic acid metabolic profile molecular dynamics mouse model neoplastic cell new therapeutic target novel strategies novel therapeutic intervention pressure prognostic programs protein function protonation public health relevance sensor structural biology tool tumor tumor heterogeneity tumor metabolism tumor progression tumorigenesis tumorigenic

项目摘要

DESCRIPTION (provided by applicant): Constitutively increased intracellular pH (pHi) is common to most cancers regardless of their tissue origin or genetic background. However, how a higher pHi enables disease progression and the molecular mechanisms mediating pHi-dependent cancer cell behaviors are understudied and mostly not understood. We previously revealed how increased pHi can enable metastatic progression by regulating pH-sensing proteins controlling directed cell migration. We now will address how increased pHi enables three additional cancer cell behaviors: tumor formation, metabolic reprograming and retention of recurring somatic mutations. We exploit our unique expertise in resolving at the molecular, cellular and tissue levels how pHi dynamics regulates cell functions. We have a strong track record of bridging structural and cell biology to reveal the design principles and functional significance of pH sensors, defined as proteins with activities or ligand binding affinities regulated within the narrow pH range of the cell. To identify pH sensors we integrate analyses of signaling pathways, cancer mutations databases, and titrating networks of ionizable residues in proteins with molecular dynamics simulations, biochemistry and cell physiology. Our expertise in measuring real-time pHi dynamics in vivo using a genetically encoded biosensor brings a distinct new approach to understanding cancer cell biology. In Aim 1 we will test the hypothesis that increased pHi is necessary and sufficient for tumorigenic behaviors. We will resolve mechanisms for pHi-dependent tumorigenesis in mouse models to determine the synthetic lethality we reported in Drosophila with loss of H+ efflux and oncogene expression. We will determine how increased pHi in the absence of oncogenes induces dysplasia, and measure spatial and temporal pHi dynamics during tumorigenesis as a new metric to inform us about heterogeneity of tumor cells. These studies include a structural and functional analysis of pH sensors predicted to enable oncogenic behaviors. In Aim 2 we will test the hypothesis that increased pHi enables metabolic reprograming in cancer. We will determine mechanisms for how increased pHi can promote a switch in glucose utilization from mitochondrial oxidative phosphorylation to increased aerobic glycolysis. These studies include a structural and functional analysis of the recognized pH-sensitive glycolytic enzymes phosphofructokinase-1 and lactate dehydrogenase. We also resolve how increased pHi suppresses mitochondrial oxidative phosphorylation and regulates carbon fates, determined by magnetic resonance spectroscopy. In Aim 3 we will test the hypothesis that increased pHi provides a selective pressure for the retention of somatic mutations with histidine residues. These studies are supported by findings from an R21 award that verified pH sensitivity of recurring somatic mutations in cancers and with bioinformatics analyses identified cancer subtypes based on amino acid substitution signatures, which we will test for shared functional properties. Outcomes of our proposal will generate new insights on molecular mechanisms enabling cancer that can inform therapeutic approaches targeting pH sensors to limit disease progression.

描述（由申请人提供）：组成性细胞内pH（pHi）升高在大多数癌症中很常见，无论其组织来源或遗传背景如何。然而，更高的pHi如何使疾病进展以及介导pH依赖性癌细胞行为的分子机制尚未得到充分研究，并且大多数都不了解。我们先前揭示了增加的pHi如何通过调节控制定向细胞迁移的pH敏感蛋白来实现转移进展。我们现在将讨论增加的pHi如何使三种额外的癌细胞行为：肿瘤形成，代谢重编程和保留复发的体细胞突变。我们利用我们独特的专业知识在分子，细胞和组织水平上解决pHi动力学如何调节细胞功能。我们在结构和细胞生物学方面有着良好的记录，可以揭示pH传感器的设计原理和功能意义，pH传感器被定义为在细胞的狭窄pH范围内调节活性或配体结合亲和力的蛋白质。为了识别pH传感器，我们整合了信号通路，癌症突变数据库和蛋白质中可电离残基的滴定网络与分子动力学模拟，生物化学和细胞生理学的分析。我们在使用基因编码生物传感器测量体内实时pHi动态方面的专业知识为理解癌细胞生物学带来了独特的新方法。在目标1中，我们将检验增加的pHi对于致瘤行为是必要且充分的这一假设。我们将在小鼠模型中解决pH依赖性肿瘤发生的机制，以确定我们在果蝇中报告的H+外排和癌基因表达丧失的合成致死性。我们将确定在没有癌基因的情况下增加的pHi如何诱导发育不良，并测量肿瘤发生过程中的空间和时间pHi动态，作为一个新的指标来告知我们肿瘤细胞的异质性。这些研究包括预测使致癌行为的pH传感器的结构和功能分析。在目标2中，我们将检验增加的pHi能够在癌症中进行代谢重编程的假设。我们将确定如何增加pHi可以促进开关的葡萄糖利用从线粒体氧化磷酸化增加有氧糖酵解的机制。这些研究包括公认的pH敏感的糖酵解酶磷酸果糖激酶-1和乳酸脱氢酶的结构和功能分析。我们还解决了如何增加pHi抑制线粒体氧化磷酸化和调节碳的命运，由磁共振光谱测定。在目标3中，我们将检验这样的假设，即增加的pHi为保留具有组氨酸残基的体细胞突变提供了选择压力。这些研究得到了R21奖项的研究结果的支持，该奖项验证了癌症中反复出现的体细胞突变的pH敏感性，并通过生物信息学分析基于氨基酸取代特征识别了癌症亚型，我们将测试这些特征的共同功能特性。我们提案的结果将产生对癌症分子机制的新见解，这些分子机制可以为靶向pH传感器的治疗方法提供信息，以限制疾病进展。